DNA-NANO-AB develops DNA-based electrochemical nanodevices for the rapid, reagentless detection of clinically relevant antibodies. The project was carried with two years spent at the University of California Santa Barbara, acquiring expertise in electrochemical biosensor design, followed by a one-year return phase at the University of Rome Tor Vergata, where the developed platforms were further advanced within a DNA nanotechnology framework.